Cleara Biotech Appoints Nicholas J. Sarlis, MD, PhD as Chief Medical Officer and Head of Clinical Development

Cleara Biotech Raises $2.5 Million in Seed Financing to Advance FOXO4-Therapeutics Pipeline for Treating Cancer and Chronic Diseases

Auron Therapeutics Announces $48 Million Series A Financing to drive novel oncology pipeline leveraging a machine learning, multi-omics based platform

Haya Therapeutics, backed by Apollo since March 2021, listed among Europe's top biotech investments

Interview with the Apollo Health Ventures Team

Haya Therapeutics raises Seed extension round and expands to San Diego

Apollo Health Ventures Closes $180 Million Fund to Drive Breakthrough Innovations Combating Age-related Diseases